CompletedNCT02626832
Arginine Vasopressin and Brain NMDA Receptor Function
About this title
Read the official source — NCT02626832Interventional studyAges 18–55United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- New Haven and 1 more locationSee all locations and recruitment
Study information
Study start dateFebruary 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02626832
- Official title
Show the full official title
Regulation of Arginine-vasopressin (AVP) in Psychiatric Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven · West Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Who was this study for?
Listed age limits: 18 years to 55 years.
